All Biobased and Renewable Products News

June 5, 2020
Workshop On Bioanalysis To Be Held By FDA

On June 30, 2020, from 9:00 a.m. to 5:30 p.m. (EDT),the U.S. Food and Drug Administration (FDA) will host a free regulatory training for industry on bioanalysis requirements and expectations. Focused on how FDA’s Center for Drug Evaluation and Research (CDER) approaches various issues in bioanalysis, the workshop aims to provide participants with a better understanding of how FDA performs bioanalysis. Topics to be covered, among others, include:

  • Bioanalytical method validation: history, process, and regulatory perspectives;
     
  • Biosimilars;
     
  • Regulated bioanalysis for large molecules;
     
  • Regulated bioanalysis for small molecules;
     
  • Drugs and biologics;
     
  • Bioanalysis of unstable analysis;
     
  • Repeat analysis; and
     
  • A case study on bioanalytical approaches to mitigate issues identified during bioequivalence clinical site inspection.

Registration is required.


 
BIOBASED AND RENEWABLE PRODUCTS ADVOCACY GROUP
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-833-6580 | www.braginfo.org
Contact
 
Privacy Policy | Acceptable Use Policy 
©2020 Biobased And Renewable Products Advocacy Group
All Rights Reserved.